Mutation(s) in DNA nucleotides in tumor promoters (Ras, APC), tumor suppressors (p16, p53, p19, Rb), cell cycles (cyclins), and DNA-repair related genes (XRCC) have been associated with prognosis and diagnosis of different cancers, although their clinical implications have yet to be established. This evidence concerns the gene APC and neoplasm.